common.study.topics.clinical

Peripheral Nerve Blocks for Lower Extremity Amputations

common.study.values.description

Peripheral Nerve Blocks for Major Lower Extremity Amputations

This study will be a double-blinded randomized controlled trial analyzing all patients who will undergo major lower extremity amputations by the vascular surgery service at UCSF Fresno between July 2017 and June 2018 to determine if regional nerve blocks (sciatic and femoral) have any effect on postoperative pain control, narcotic requirements, and length of stay compared with standard post-operative narcotic regimens.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Bupivacaine

Patients randomized to the treatment group will receive regional nerve blocks (sciatic and femoral) with bupivacaine at the dose of 1 mg/kg.

Drug - Saline Solution

Patients randomized to the control group will receive two needle sticks (in the sciatic and femoral distributions) with normal saline to maintain the double-blinded investigation.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Peripheral Nerve Blocks for Major Lower Extremity Amputations

common.study.values.clinical-trial-id

NCT03174782

participant.views.study.view.id

PdRyqb